Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

Regeneron’s gene therapy, dubbed DB-OTO, is a cell-selective AAV gene therapy for children with hearing loss stemming from a ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Sensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...

Here's why a gene therapy product originally developed at CHOP spinout Spark Therapeutics was shelved by Pfizer.

"We have, for the first time, an effective treatment for the most severe form of childhood blindness, and a potential ...

Hyderabad: Cell and gene therapy solutions provider Miltenyi Biotec on Monday announced the roll-out of what is touted as ...

Miltenyi Biotec opens cell and gene therapy center in Hyderabad, advancing medical research and innovation in Life Sciences.

Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...

12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

Miltenyi Biotec launches India's first dedicated Cell and Gene Therapy Center of Excellence in Hyderabad, aiming to advance ...